See more : comScore, Inc. (SCOR) Income Statement Analysis – Financial Results
Complete financial analysis of Kronos Advanced Technologies Inc. (KNOS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kronos Advanced Technologies Inc., a leading company in the Industrial – Pollution & Treatment Controls industry within the Industrials sector.
- Silver Bullet Mines Corp. (SBMCF) Income Statement Analysis – Financial Results
- illumin Holdings Inc. (ILLM.TO) Income Statement Analysis – Financial Results
- Nano Magic Holdings Inc. (NMGX) Income Statement Analysis – Financial Results
- Tidewater Midstream and Infrastructure Ltd. (TWMIF) Income Statement Analysis – Financial Results
- Ascension Capital Limited (ACE.NZ) Income Statement Analysis – Financial Results
Kronos Advanced Technologies Inc. (KNOS)
Industry: Industrial - Pollution & Treatment Controls
Sector: Industrials
Website: https://kronosati.co
About Kronos Advanced Technologies Inc.
Kronos Advanced Technologies Inc. manufactures, distributes, and licenses air movement and purification devices in the United States. The company offers air purifiers and masks. It markets and sells products directly through our website, 1800safeair.com, as well as through independent sales representatives. The company was formerly known as TSET, Inc. and changed its name to Kronos Advanced Technologies Inc. in January 2001. Kronos Advanced Technologies Inc. was incorporated in 1980 and is headquartered in Parkersburg, West Virginia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.10K | 135.93K | 83.00K | 503.74K | 41.22K | 616.00 | 3.67M | 160.48K | 219.37K | 430.38K | 533.22K | 558.59K | 92.59K | 95.00K | 306.07K |
Cost of Revenue | 17.26K | 13.10K | 50.87K | 276.08K | 6.76K | 183.00 | 340.99K | 93.37K | 8.45K | 375.40K | 379.33K | 314.50K | 77.59K | 62.50K | 244.03K |
Gross Profit | 3.85K | 122.83K | 32.14K | 227.66K | 34.46K | 433.00 | 3.32M | 67.11K | 210.92K | 54.98K | 153.89K | 244.09K | 15.00K | 32.50K | 62.04K |
Gross Profit Ratio | 18.22% | 90.36% | 38.72% | 45.19% | 83.61% | 70.29% | 90.70% | 41.82% | 96.15% | 12.78% | 28.86% | 43.70% | 16.20% | 34.21% | 20.27% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 356.83K | 188.10K | 357.82K | 167.50K | 60.52K | 116.25K | 224.09K | 297.00K | 0.00 |
General & Administrative | 0.00 | 512.04K | 382.22K | 2.16M | 171.33K | 14.54K | 3.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 4.03K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 7.88K | 512.04K | 382.22K | 2.17M | 171.33K | 14.54K | 3.82M | 4.24M | 2.75M | 2.13M | 1.67M | 2.51M | 2.89M | 2.50M | 2.01M |
Other Expenses | -72.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | -64.42K | 512.04K | 382.22K | 2.17M | 171.33K | 14.54K | 4.62M | 4.91M | 3.73M | -1.09M | 2.09M | 2.91M | 3.38M | 3.39M | 2.25M |
Cost & Expenses | -47.16K | 525.14K | 433.08K | 2.44M | 178.09K | 14.73K | 4.96M | 5.00M | 3.74M | -710.13K | 2.47M | 3.23M | 3.46M | 3.45M | 2.49M |
Interest Income | 0.00 | 67.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 67.50K | 920.96K | 425.47K | 375.00K | 648.72K | 367.94K | 489.25K | 521.10K | 615.83K | 0.00 | 100.52K | 6.13K | 0.00 |
Depreciation & Amortization | 15.75K | 21.00K | 21.00K | 21.00K | 15.75K | 14.11K | 448.26K | 479.28K | 618.25K | 475.25K | 360.96K | 284.65K | 286.70K | 332.53K | 242.47K |
EBITDA | 27.48K | -368.21K | -329.08K | -1.92M | -231.80K | 0.00 | -3.26M | -4.36M | -2.90M | -2.24M | -1.57M | -2.38M | -3.08M | -3.23M | -1.31M |
EBITDA Ratio | 130.19% | -270.88% | -396.47% | -381.15% | -293.89% | -2,290.58% | 42.52% | -4,496.95% | -1,326.71% | 1,271.39% | -305.71% | -441.67% | -3,326.58% | -2,679.34% | -428.90% |
Operating Income | 68.26K | -389.21K | -350.08K | -1.94M | -136.88K | -14.11K | -1.55M | -4.84M | -3.52M | -2.72M | -1.94M | -2.67M | -3.37M | -3.36M | -2.19M |
Operating Income Ratio | 323.47% | -286.33% | -421.77% | -385.32% | -332.10% | -2,290.58% | -42.34% | -3,015.80% | -1,604.54% | -631.29% | -362.90% | -477.70% | -3,635.53% | -3,535.41% | -714.06% |
Total Other Income/Expenses | -1.34M | -67.48K | -71.89K | 475.89K | -356.57K | -375.00K | -2.57B | 2.86M | -480.48K | -3.86M | -559.83K | -101.47K | -99.88K | -213.92K | -630.33K |
Income Before Tax | -1.27M | -456.69K | -421.97K | -1.47M | -493.44K | -389.11K | -3.96M | -1.98M | -3.51M | -6.57M | -2.49M | -2.77M | -3.47M | -3.57M | -2.82M |
Income Before Tax Ratio | -6,005.47% | -335.97% | -508.38% | -290.85% | -1,197.24% | -63,167.05% | -108.07% | -1,236.00% | -1,600.54% | -1,527.26% | -467.89% | -495.86% | -3,743.41% | -3,760.59% | -920.01% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 425.47K | -14.11K | 3.06M | -2.49M | 480.48K | 8.23M | 559.83K | 101.47K | -581.93K | 6.51M | 672.12K |
Net Income | -1.27M | -456.69K | -421.97K | -1.47M | -493.44K | -389.11K | -4.36M | -2.35M | -4.00M | -7.09M | -2.49M | -2.77M | -2.78M | -9.87M | -2.86M |
Net Income Ratio | -6,005.47% | -335.97% | -508.38% | -290.85% | -1,197.24% | -63,167.05% | -118.85% | -1,465.28% | -1,823.57% | -1,648.34% | -467.89% | -495.86% | -3,007.03% | -10,385.35% | -933.66% |
EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.04 | -0.10 | -0.04 | -0.06 | -0.06 | -0.31 | -0.11 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.04 | -0.10 | -0.04 | -0.06 | -0.06 | -0.31 | -0.11 |
Weighted Avg Shares Out | 668.07M | 45.67M | 659.32M | 659.32M | 489.19M | 487.69M | 366.82M | 200.02M | 98.51M | 67.61M | 57.76M | 48.26M | 45.14M | 31.48M | 25.26M |
Weighted Avg Shares Out (Dil) | 667.83M | 659.32M | 659.32M | 659.32M | 489.19M | 487.69M | 366.82M | 200.02M | 98.51M | 67.61M | 57.76M | 48.26M | 45.14M | 31.48M | 25.26M |
Kronos Advanced Technologies Will Begin Selling US-Made FDA/NIOSH Approved PPE Next Week
KRONOS ADVANCED TECHNOLOGIES INC RESUMES REGULAR SHIPPING OF ONLINE ORDERS
Source: https://incomestatements.info
Category: Stock Reports